A. Gutiérrez

发表

Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

A. Salar, J. Sancho, M. Terol, 2019, Cancer medicine.

xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies

J. Besalduch, A. Gutiérrez, Jordi Ginés, 2014, OncoTargets and therapy.

Therapeutic concepts in mantle cell lymphoma

F. Cabanillas, S. Fernández de Mattos, A. Obrador-Hevia, 2010, European journal of haematology.

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.

J. Blay, A. Italiano, E. de Álava, 2019, The Lancet. Oncology.

Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD.

Juan F. García, L. Sánchez, A. Gutiérrez, 2012, Blood.

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience

C. Solano, L. Bento, M. Bastos-Oreiro, 2022, Cancers.

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

G. Gutiérrez-García, C. Solano, J. Pérez-Simón, 2021, Bone Marrow Transplantation.

Potential survival benefit for patients receiving allogeneic hematopoietic stem cell transplantation after nivolumab therapy for relapse/refractory Hodgkin lymphoma: Real-life experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO).

C. Martínez, J. Bargay, R. García-Sanz, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma

A. Salar, A. Navarro, Jordi Martínez, 2022, Cancers.

Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups

A. Salar, P. Abrisqueta, J. Sancho, 2022, Frontiers in Immunology.

Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma

L. Bento, A. Gutiérrez, A. Sampol, 2018, OncoTargets and therapy.

SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment

L. Bento, Antonia Rodríguez, A. Sureda, 2021, Cancers.

Prognostic Role of the Red Blood Cell Distribution Width (RDW) in Hodgkin Lymphoma

J. Ibarra, J. Bargay, L. Bento, 2020, Cancers.

MRP1 Overexpression Determines Poor Prognosis in Prospectively Treated Patients with Localized High-Risk Soft Tissue Sarcoma of Limbs and Trunk Wall: An ISG/GEIS Study

A. D. Dei Tos, P. Casali, S. Ferrari, 2013, Molecular Cancer Therapeutics.

Rapid triplex asymmetric real-time PCR hybridization probe assay for the joint genotyping of F2, F5 and F12.

A. Gutiérrez, J. Martínez-Serra, T. Ros, 2009, Clinical biochemistry.

New real-time PCR-based method for the joint genotyping of JAK2 (V617F) with inherited thrombophilic F5 and F2 mutations.

J. Besalduch, A. Gutiérrez, J. Martínez-Serra, 2009, Clinica chimica acta; international journal of clinical chemistry.

Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma.

A. Gutiérrez, J. Rodriguez, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Characterization of Monoclonal Gammopathy of Undetermined Significance by Calorimetric Analysis of Blood Serum Proteome

J. Portugal, A. Gutiérrez, F. Barceló, 2015, PloS one.

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study

J. Martín-Broto, A. de Juan, A. Poveda, 2021, Cancers.

Gemcitabine and Oxaliplatinum: An Effective Regimen in a Patient with Progressive Refractory Mantle Cell Lymphoma

J. Besalduch, A. Gutiérrez, A. Sampol, 2004, Leukemia & lymphoma.

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

C. Balañà, J. Martín-Broto, J. Maurel, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study

J. Martín-Broto, J. López-Guerrero, M. Tarón, 2020, Cancers.

Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of action.

J. Besalduch, A. Gutiérrez, R. Alemany, 2011, European journal of pharmacology.

Pathogenic study of anti-CD20 infusion-related severe refractory shock in diffuse large B-cell lymphoma

J. Pons, Jordi Martínez, J. Besalduch, 2006, Leukemia & lymphoma.

Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers.

E. González-Barca, C. Solano, R. Martino, 2021, Transplantation and cellular therapy.

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.

J. Carles, A. Llombart‐Bosch, R. Andrés, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

C. Martínez, R. García-Sanz, Antonia Rodríguez, 2016 .

Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity

Juan F. García, L. Colomo, A. Salar, 2021, Blood advances.

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.

J. Blay, J. Dopazo, A. Italiano, 2019, The Lancet. Oncology.

Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial.

J. Blay, J. Dopazo, E. de Álava, 2020, The Lancet. Oncology.

Fluorescence resonance energy transfer-based real-time polymerase chain reaction method without DNA extraction for the genotyping of F5, F2, F12, MTHFR, and HFE

J. Besalduch, A. Noguera, A. Gutiérrez, 2014, Journal of blood medicine.

Four-channel asymmetric Real-Time PCR hybridization probe assay: a rapid pre-screening method for critical BCR-ABL kinase domain mutations.

J. Besalduch, S. Soverini, A. Gutiérrez, 2012, Clinical biochemistry.

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

J. Martín-Broto, C. Valverde, V. Martínez-Marín, 2022, Nature Communications.

New treatment concepts in diffuse large B-cell lymphomas (DLBL): chemothe-rapy and biological therapy.

J. Rodríguez, A. Gutiérrez, 2007, Reviews on recent clinical trials.

Diffuse large B-cell lymphoma in the older.

G. Pérez-Manga, A. Gutiérrez, J. Rodriguez, 2011, Critical reviews in oncology/hematology.

Long-term hematological reconstitution and clinical evaluation of autologous peripheral blood stem cell transplantation after cryopreservation of cells with 5% and 10% dimethylsulfoxide at -80 degrees C in a mechanical freezer.

P. Galan, Jordi Martínez, J. Besalduch, 2007, Haematologica.

RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group

A. López-Guillermo, A. Salar, E. González-Barca, 2020, Annals of Hematology.

Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.

B. Martínez-Delgado, G. Pérez-Manga, A. Gutiérrez, 2009, Critical reviews in oncology/hematology.

The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma.

C. Solano, J. Rodríguez, J. Lahuerta, 2007, Haematologica.

The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience.

R. Arranz, A. Gutiérrez, M. Caballero, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.

A. F. Sevilla, José Raúl Rodríguez Rodríguez, J. San-Miguel, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.

A. López-Guillermo, J. Sierra, J. Rodríguez, 2003, Haematologica.

Frontline autologous stem cell transplantation in high‐risk peripheral T‐cell lymphoma: a prospective study from The Gel‐Tamo Study Group

J. Rodríguez, R. Arranz, A. Gutiérrez, 2007, European journal of haematology.

Prolonged survival of patients with angioimmunoblastic T‐cell lymphoma after high‐dose chemotherapy and autologous stem cell transplantation. The GELTAMO experience

J. Rodríguez, J. Ribera, J. Moraleda, 2007, European journal of haematology.

Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases

F. Sartori, A. Gutiérrez, A. Sampol, 2016, Experimental Hematology & Oncology.

Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis

J. Besalduch, L. Bento, R. del Campo, 2014, Biomarker Research.

GEMOX‐R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large‐cell lymphoma: a phase II study

Jordi Martínez, A. Palacios, A. Gutiérrez, 2007, European journal of haematology.

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups

J. Blay, A. Italiano, A. D. Dei Tos, 2019, EClinicalMedicine.

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.

C. Antonescu, J. Donohue, M. Gönen, 2009, The Lancet. Oncology.

Inhibition of c-Myc Down-Regulation by Sustained Extracellular Signal-Regulated Kinase Activation Prevents the Antimetabolite Methotrexate- and Gemcitabine-Induced Differentiation in Non-Small-Cell Lung Cancer Cells

J. Besalduch, A. Gutiérrez, A. Sampol, 2008, Molecular Pharmacology.

Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study

J. Martín-Broto, A. Obrador-Hevia, J. López-Guerrero, 2020, Cancers.

Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas

J. Martín-Broto, A. Gutiérrez, F. Barceló, 2012, PloS one.

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.

C. de Miguel, C. Solano, J. González-Porras, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

J. Blay, J. Dopazo, J. Coindre, 2021, Molecular Cancer Therapeutics.

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

A. Llombart‐Bosch, J. Maurel, J. López-Guerrero, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience.

A. López-Guillermo, A. F. Sevilla, J. Sierra, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center

J. Martín-Broto, D. Moura, N. Hindi, 2020, Cancers.

Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin–tazobactam

C. Solano, D. Navarro, C. Gimeno, 2005, Bone Marrow Transplantation.

Efficacy of the GemOx‐R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma

L. Belayachi, S. Fernández de Mattos, P. Villalonga, 2016, British journal of haematology.

Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial.

J. Blay, J. Coindre, A. Italiano, 2020, JAMA oncology.

A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin

J. Dopazo, J. Martín-Broto, C. Romagosa, 2021, Molecular oncology.

Phase II trial of gemcitabine plus rapamycin as second line in advanced osteosarcoma: A Spanish Group for Sarcoma Research (GEIS) Study.

J. Mora, C. Valverde, J. Broto, 2015 .

Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma

P. Galan, J. Besalduch, J. Rodríguez, 2014, OncoTargets and therapy.

Hematopoietic SCT for peripheral T-cell lymphoma

G. Pérez-Manga, A. Gutiérrez, M. Caballero, 2008, Bone Marrow Transplantation.

Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS).

J. Martín-Broto, C. Valverde, A. de Juan, 2018, The oncologist.

Differential prognostic impact of GELTAMO‐IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm

Juan F. García, A. Salar, J. Sancho, 2018, British Journal of Haematology.

Validation of the NCCN‐IPI for diffuse large B‐cell lymphoma (DLBCL): the addition of β2‐microglobulin yields a more accurate GELTAMO‐IPI

Juan F. García, A. López-Guillermo, A. Salar, 2017, British journal of haematology.

Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma

S. Fernández de Mattos, Jordi Martínez, J. Rodríguez, 2007, Leukemia & lymphoma.

Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial

J. Dopazo, E. de Álava, J. Martín-Broto, 2020, Journal for ImmunoTherapy of Cancer.

Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

J. Sancho, M. Federico, M. Ramírez, 2022, Haematologica.

Frontline autologous stem cell transplantation for peripheral T-cell lymphoma

J. Rodríguez, A. Gutiérrez, José Rodríguez, 2009, Expert review of hematology.

International single-arm phase II trial of pazopanib in advanced extraskeletal myxoid chondrosarcoma: A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study.

J. Blay, E. Álava, A. Italiano, 2017 .

Multi-institutional European single-arm phase II trial of pazopanib in advanced malignant/dedifferentiated solitary fibrous tumors (SFT): A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) sarcoma groups study.

J. Blay, E. Álava, A. Italiano, 2017 .

Prognostic value of serum CA125 levels in diffuse large B‐cell lymphoma: potential role of a new sex‐ and age‐adjusted reference value

J. Besalduch, B. Barceló, A. Gutiérrez, 2010, International journal of laboratory hematology.

Cell-Free DNA dynamic concentration and other variables are predictors of early progression after CAR T-Cell therapy in DLBCL patients.: cfDNA dynamics pre CAR-T in DLBCL.

I. Buño, J. Díez-Martín, F. Díaz-Crespo, 2023, Transplantation and cellular therapy.

Reconstitution of lymphocyte populations and cytomegalovirus viremia or disease after allogeneic peripheral blood stem cell transplantation

I. Marugán, I. Benet, J. Garcia-conde, 2003, Journal of medical virology.

Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

C. Martínez, Arturo Pereira, R. García-Sanz, 2022, Annals of Hematology.

Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14

A. Salar, J. Besalduch, J. Bargay, 2015, PloS one.

Gemcitabine and Oxaliplatinum (GemOx): An Effective Regimen in Patients with Refractory and Relapsing Hodgkin Lymphoma

P. Galan, J. Rodríguez, J. Bargay, 2012 .

[Malignant fibrous histiocytoma of soft tissue: description of 10 cases].

J. Povar, P. Arazo, A. Gutiérrez, 1991, Medicina clinica.

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients

J. Martín-Broto, C. Serrano, J. López-Guerrero, 2018, Oncotarget.

Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era

Juan F. García, A. López-Guillermo, A. Salar, 2019, European journal of haematology.

New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma treated with R‐CHOP: Spanish Lymphoma Group Experience (GELTAMO)

A. Salar, P. Abrisqueta, J. Sancho, 2019, British journal of haematology.

Primary mediastinal large cell lymphoma (PMBL): frontline treatment with autologous stem cell transplantation (ASCT). The GEL‐TAMO experience

J. Rodríguez, J. Lahuerta, A. Gutiérrez, 2008, Hematological oncology.

Total Lesion Glycolysis Improves Tumor Burden Evaluation and Risk Assessment at Diagnosis in Hodgkin Lymphoma

J. Ibarra, J. Bargay, L. Bento, 2021, Journal of clinical medicine.

Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience

A. Cladera, J. Bargay, F. Sartori, 2017, PloS one.

Current Real-Life Results and Future Options of Gemcitabine-Based Salvage Therapy for Relapsed or Refractory Non-Hodgkin Lymphoma

A. Gutiérrez, 2019, Acta Haematologica.

Primary mediastinal B-cell lymphoma: Treatment and therapeutic targets

M. Piris, J. Rodríguez, A. Gutiérrez, 2008, Leukemia & lymphoma.

Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2

A. Chaudhry, M. Ufkin, H. Prince, 2022, Blood.

Treatment with alemtuzumab in a case of refractory primary cutaneous CD30‐negative CD8‐positive cytotoxic large T‐cell lymphoma

J. Besalduch, J. Rodríguez, A. Gutiérrez, 2004, European Journal of Haematology.

Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report

L. Bento, A. Gutiérrez, A. Sampol, 2016, OncoTargets and therapy.

Radiation therapy overcomes adverse prognostic role of cyclooxygenase-2 expression on Reed-Sternberg cells in early Hodgkin lymphoma.

Juan F. García, J. Besalduch, C. Nicolau, 2015, International journal of radiation oncology, biology, physics.

Analysis of Personality Traits in Patients with Hodgkin Lymphoma

A. Salar, J. Bargay, L. Bento, 2021, Journal of clinical medicine.

Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma: A Nonrandomized Clinical Trial.

J. Blay, A. Italiano, A. D. Dei Tos, 2023, JAMA oncology.

Retrospective world-wide registry on the efficacy of immune checkpoint inhibitors in alveolar soft part sarcoma: Updated results from sixty patients.

J. Blay, W. Tap, P. Rutkowski, 2021 .

Trabectedin and radiotherapy in soft-tissue sarcoma (TRASTS) study: An international, prospective, phase II trial in localized myxoid liposarcoma—A collaborative Spanish (GEIS), Italian (ISG) and French (FSG) group study.

J. Blay, A. Gronchi, C. Morosi, 2020 .

Front-Line Autologous Stem Cell Transplantation (ASCT) in Primary Mediastinal Large B-Cell Lymphoma: The GEL-TAMO Experience.

J. Rodríguez, J. Lahuerta, J. C. García-Ruiz, 2006 .

Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy

Juan F. García, B. Bellosillo, L. Colomo, 2022, Blood advances.

IMMUNOSARC: a collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib and nivolumab in advanced soft tissue and bone sarcoma: Results from the phase II part, bone sarcoma cohort.

E. Álava, P. Casali, P. Picci, 2020 .

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

J. Mora, J. Martín-Broto, A. Carnero, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD.

Juan F. García, A. Gutiérrez, T. Ros, 2012, Blood.

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups

J. Blay, A. Italiano, A. D. Dei Tos, 2019, EClinicalMedicine.

Erratum: Hindi, N., et al. Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center. Cancers 2020, 12, 3740

J. Martín-Broto, D. Moura, N. Hindi, 2021, Cancers.

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

J. Blay, A. Italiano, J. Martín-Broto, 2023, Molecular Cancer.

Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study

A. Gutiérrez, J. García-Marco, J. Hernández‐Rivas, 2023, Cancers.

Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients

O. Delgado Sánchez, L. Bento, A. Gutiérrez, 2019, ClinicoEconomics and outcomes research : CEOR.

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

C. Martínez, J. Bargay, R. García-Sanz, 2018, Blood.